Filter
8089
Filtered Results: 8089
Text search:
Health
and
Human
Rights
Info
Featured
Recommendations
743
New Publications
2046
Language
Document type
No document type
4450
Studies & Reports
1395
Guidelines
994
Manuals
486
Strategic & Response Plan
325
Fact sheets
160
Training Material
149
Situation Updates
64
Brochures
23
Infographics
22
Resource Platforms
13
Online Courses
6
App
1
Videos
1
Countries / Regions
Global
374
India
271
Kenya
233
South Africa
156
Ethiopia
155
Sierra Leone
150
Nepal
149
Nigeria
146
Uganda
142
Western and Central Europe
138
Latin America and the Carribbean
133
Myanmar / Burma
129
Liberia
125
Bangladesh
118
Zambia
112
Syria
111
Tanzania
104
Malawi
100
Africa
96
Ghana
94
Rwanda
91
Ukraine
85
Namibia
68
Congo, Democratic Republic of
66
Philippines
65
South Sudan
60
South–East Asia Region
58
Indonesia
53
Lesotho
50
Venezuela
49
Cambodia
47
Asia
47
Eastern Europe
47
Mozambique
43
Yemen
43
Zimbabwe
42
West and Central Africa
41
Guinea
38
East and Southern Africa
37
Middle East and North Africa
36
Germany
35
Brazil
35
Haiti
34
Colombia
31
Senegal
31
Eastern Europe and Central Asia
30
Botswana
29
Cameroon
26
Russia
26
Afghanistan
24
Central African Republic
24
Pakistan
24
Burkina Faso
23
Eswatini/ Swaziland
21
Western Pacific Region
20
Lebanon
20
Sudan
20
Thailand
17
Jordan
17
Vietnam
17
Somalia
16
Moldova
15
Tajikistan
14
Laos
14
Iraq
14
China
13
Albania
13
Georgia
12
Mali
12
Sri Lanka
11
Turkey
10
North America
10
Iran
9
Peru
9
USA
9
Papua New Guinea
9
Paraguay
8
Bolivia
8
Palestine
8
Angola
8
Chile
7
Côte d’Ivoire / Ivory Coast
7
Greece
7
Poland
7
Libya
7
Madagascar
7
North Macedonia
6
Mexico
6
Hungary
6
Jamaica
6
Argentina
6
Timor Leste/ East Timor
5
Benin
5
Gambia
5
Kyrgyzstan
5
Niger
5
Armenia
5
Guinea-Bissau
5
Turkmenistan
5
Portugal
5
Southern Africa
5
Egypt
5
Romania
5
Chad
5
Ecuador
5
El Salvador
4
Serbia
4
Kazakhstan
4
Uzbekistan
4
Burundi
4
Italy
4
United Kingdom
4
Spain
4
Togo
3
Canada
3
Malaysia
3
Croatia
3
Saudi Arabia
3
Japan
3
Belarus
3
Bosnia and Herzegovina
3
Honduras
3
Bhutan
3
Guatemala
3
Fiji
2
Singapore
2
Estonia
2
Morocco
2
Bulgaria
2
Lithuania
2
Mauritius
2
Tunisia
2
Azerbaijan
2
Nicaragua
2
Djibouti
2
Slovakia
2
North Korea
1
Switzerland
1
Australia
1
Vanuatu
1
Mongolia
1
Qatar
1
Mauritania
1
Dominican Republic
1
Ireland
1
Gabon
1
Denmark
1
Belgium
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Solomon Islands
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
2753
Key Resources
562
Clinical Guidelines
541
Women & Child Health
479
Public Health
426
Capacity Building
165
Pharmacy & Technologies
82
Annual Report MEDBOX
3
Toolboxes
HIV
670
COVID-19
666
Mental Health
662
Disability
453
TB
355
Planetary Health
320
Conflict
275
Caregiver
223
Rapid Response
218
Refugee
209
NTDs
208
AMR
199
Ebola & Marburg
178
Global Health Education
171
Pharmacy
126
Natural Hazards
115
Health Financing Toolbox
93
Malaria
93
NCDs
87
Social Ethics
51
Specific Hazards
47
Zika
47
Cholera
35
Polio
31
Typhoon
3
South Sudan
2
The far-reaching impacts of the COVID-19 pandemic underscore the critical need for evidence-informed, transparent and inclusive decision-making. Policy-makers have grappled with complex choices amidst uncertainty. They have constantly reassessed response measures while navigating their economic impl...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
This document aims to support those working in primary care to strengthen IPC, informed by existing WHO IPC guidance and implementation resources. Many of the existing WHO IPC guidance and implementation resources initially developed for acute health care facilities have a potential utility for IPC ...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
The Interim Guidance for Risk Communication and Community Engagement (RCCE) outlines recommendations, considerations and methods to raise awareness, manage risk perception, maintain trust and proactively support people at risk to make informed decisions to protect themselves and others from monkeypo...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
The document "Combating False Information on Vaccines: A Guide for EPI Managers" is designed to help Expanded Program on Immunization (EPI) managers address vaccine misinformation. It begins by defining misinformation and explaining why it spreads rapidly, often due to its emotional appeal and simpl...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19
recommended
Updated Interim guidance 29 July 2020
The provision of safe water, sanitation and waste management and hygienic conditions is essential for preventing and for protecting human health during all infectious disease outbreaks, including of coronavirus disease 2019 (COVID-19). Ensuring evidenced-based ...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public health response. The operational intelligence complements the epidemiologic information used to drive a global...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re...
An estimated 59 000 people die from rabies each year. That’s one person every nine minutes of every day, 40% of whom are children living in Asia and Africa. As dog bites cause almost all human cases, we can prevent rabies deaths by increasing awareness, vaccinating dogs to prevent the disease at i...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other...
